Barnea A

References (7)

Title : Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations - Torgeman_2017_Toxins.(Basel)_9_
Author(s) : Torgeman A , Ozeri E , Ben David A , Diamant E , Rosen O , Schwartz A , Barnea A , Makovitzki A , Mimran A , Zichel R
Ref : Toxins (Basel) , 9 : , 2017
Abstract : Torgeman_2017_Toxins.(Basel)_9_
ESTHER : Torgeman_2017_Toxins.(Basel)_9_
PubMedSearch : Torgeman_2017_Toxins.(Basel)_9_
PubMedID: 28555060

Title : Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins - Rosen_2016_Toxins.(Basel)_8_
Author(s) : Rosen O , Ozeri E , Barnea A , David AB , Zichel R
Ref : Toxins (Basel) , 8 : , 2016
Abstract : Rosen_2016_Toxins.(Basel)_8_
ESTHER : Rosen_2016_Toxins.(Basel)_8_
PubMedSearch : Rosen_2016_Toxins.(Basel)_8_
PubMedID: 27669303

Title : Early, Real-Time Medical Diagnosis of Botulism by Endopeptidase-Mass Spectrometry - Rosen_2015_Clin.Infect.Dis_61_e58
Author(s) : Rosen O , Feldberg L , Gura S , Brosh-Nissimov T , Guri A , Zimhony O , Shapiro E , Beth-Din A , Stein D , Ozeri E , Barnea A , Turgeman A , Ben David A , Schwartz A , Elhanany E , Diamant E , Yitzhaki S , Zichel R
Ref : Clin Infect Dis , 61 :e58 , 2015
Abstract : Rosen_2015_Clin.Infect.Dis_61_e58
ESTHER : Rosen_2015_Clin.Infect.Dis_61_e58
PubMedSearch : Rosen_2015_Clin.Infect.Dis_61_e58
PubMedID: 26420800

Title : Expression, purification and characterization of the receptor-binding domain of botulinum neurotoxin serotype B as a vaccine candidate - Ben David_2015_Protein.Expr.Purif_110_122
Author(s) : Ben David A , Torgeman A , Barnea A , Zichel R
Ref : Protein Expr Purif , 110 :122 , 2015
Abstract : Ben David_2015_Protein.Expr.Purif_110_122
ESTHER : Ben David_2015_Protein.Expr.Purif_110_122
PubMedSearch : Ben David_2015_Protein.Expr.Purif_110_122
PubMedID: 25727047

Title : Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations - Diamant_2014_PLoS.One_9_e87089
Author(s) : Diamant E , Lachmi BE , Keren A , Barnea A , Marcus H , Cohen S , David AB , Zichel R
Ref : PLoS ONE , 9 :e87089 , 2014
Abstract : Diamant_2014_PLoS.One_9_e87089
ESTHER : Diamant_2014_PLoS.One_9_e87089
PubMedSearch : Diamant_2014_PLoS.One_9_e87089
PubMedID: 24475231

Title : The receptor binding domain of botulinum neurotoxin serotype A (BoNT\/A) inhibits BoNT\/A and BoNT\/E intoxications in vivo - Ben David_2013_Clin.Vaccine.Immunol_20_1266
Author(s) : Ben David A , Diamant E , Barnea A , Rosen O , Torgeman A , Zichel R
Ref : Clin Vaccine Immunol , 20 :1266 , 2013
Abstract : Ben David_2013_Clin.Vaccine.Immunol_20_1266
ESTHER : Ben David_2013_Clin.Vaccine.Immunol_20_1266
PubMedSearch : Ben David_2013_Clin.Vaccine.Immunol_20_1266
PubMedID: 23761665

Title : Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system - Zichel_2010_Clin.Vaccine.Immunol_17_784
Author(s) : Zichel R , Mimran A , Keren A , Barnea A , Steinberger-Levy I , Marcus D , Turgeman A , Reuveny S
Ref : Clin Vaccine Immunol , 17 :784 , 2010
Abstract : Zichel_2010_Clin.Vaccine.Immunol_17_784
ESTHER : Zichel_2010_Clin.Vaccine.Immunol_17_784
PubMedSearch : Zichel_2010_Clin.Vaccine.Immunol_17_784
PubMedID: 20357058